|
| 36948922 | Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer. | Clin Genitourin Cancer | 2023 |
| 32961119 | Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial. | Lancet Oncology, The | 2020 |
| 30530595 | Characterization of Mauritian Cynomolgus Macaque FcγR Alleles Using Long-Read Sequencing. | Journal of Immunology | 2019 |
| 25585297 | High Reproducibility of ELISPOT Counts from Nine Different Laboratories. | Cells | 2015 |
| 19889785 | Effective simian immunodeficiency virus-specific CD8+ T cells lack an easily detectable, shared characteristic. | Journal of Virology | 2010 |
| 20686015 | Simian immunodeficiency virus-specific CD8+ T cells recognize Vpr- and Rev-derived epitopes early after infection. | Journal of Virology | 2010 |
| 20812010 | Simian immunodeficiency virus-specific CD4+ T cells from successful vaccinees target the SIV Gag capsid. | Immunogenetics | 2010 |
| 20219903 | High viremia is associated with high levels of in vivo major histocompatibility complex class I Downregulation in rhesus macaques infected with simian immunodeficiency virus SIVmac239. | J Virol | 2010 |
| 19339351 | Mauritian cynomolgus macaques share two exceptionally common major histocompatibility complex class I alleles that restrict simian immunodeficiency virus-specific CD8+ T cells. | J Virol | 2009 |
| 19494300 | Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. | J Immunol | 2009 |
| 19403685 | Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. | J Virol | 2009 |
| 19726517 | Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques. | J Virol | 2009 |
| 18385251 | Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques. | J Virol | 2008 |
| 17989178 | The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers. | J Virol | 2008 |
| 18057253 | Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication. | Journal of Virology | 2008 |
| 18000532 | CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation. | PLoS One | 2007 |
| 17642000 | HIV Vaccines: from basic research to clinical trials--Keystone Symposia. | IDrugs : the investigational drugs journal | 2007 |
| 17641886 | Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes. | Immunogenetics | 2007 |
| 17312117 | Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. | J Immunol | 2007 |
| 17537848 | Mamu-B*08-positive macaques control simian immunodeficiency virus replication. | J Virol | 2007 |
| 17192314 | The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape. | Journal of Virology | 2007 |
| 17135324 | Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replication. | Journal of Virology | 2007 |
| 16960778 | Repeated intravaginal inoculation with cell-associated simian immunodeficiency virus results in persistent infection of nonhuman primates. | Journal of Infectious Diseases | 2006 |
| 16282500 | Tat(28-35)SL8-specific CD8+ T lymphocytes are more effective than Gag(181-189)CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay. | Journal of Virology | 2005 |
| 16137805 | A computational resource for the prediction of peptide binding to Indian rhesus macaque MHC class I molecules. | Vaccine | 2005 |
| 15747117 | Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity. | Immunogenetics | 2005 |
| 16306626 | Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques. | Journal of Virology | 2005 |
| 16237093 | The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B*01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239. | J Immunol | 2005 |
| 15470050 | Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition. | J Immunol | 2004 |
| 12885919 | Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. | J Virol | 2003 |